The authors therefore recommend a prospective randomized control trial to establish the risk of mortality with hyponatraemia and match other confounders such as the clinical diagnoses, serum albumin, and serum protein and to exclude patients with other comorbidities which may confound as independent predictors of mortality. Here, ALB is linked to Hyponatremia.